204
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Low positive rate of serum autoantibodies in colorectal cancer patients without systemic rheumatic diseases

, , , , &
Pages 383-387 | Received 06 Nov 2015, Accepted 06 Jun 2016, Published online: 16 Jul 2016

References

  • Hernandez Ramirez, D. F. and J. Cabiedes. 2010. Immunological techniques that support the diagnosis of the autoimmune diseases. Reumatol. Clin. 6: 173–177.
  • Liu, W., Z. Li, W. Xu, et al. 2013. Humoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62) and its tissue-specific expression in colon cancer. Scand. J. Immunol. 77: 255–260.
  • Solans Laqué, R., C. Pérez Bocanegra, A. Salud Salvia, et al. 2004. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes. Lupus. 13: 159–164.
  • Tschernatsch, M., E. Stolz, M. Strittmatter, et al. 2005. Antinuclear antibodies define a subgroup of paraneoplastic neuropathies: clinical and immunological data. J. Neurol. Neurosurg. Psychiatry. 76: 1702–1706.
  • Fernández-Madrid, F., P. J. VandeVord, X. Yang, et al. 1999. Antinuclear antibodies as potential markers of lung cancer. Clin. Cancer. Res. 5: 1393–1400.
  • Fenger, M., A. Wiik, M. Høier-Madsen, et al. 2004. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin. Chem. 50: 2141–2147.
  • Solomon, D. H., A. J. Kavanaugh, P. Schur, et al. 2002. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis. Rheum. 4: 434–444.
  • Bossuyt, X., and A. Luyckx. 2005. Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples. Clin. Chem. 51: 2426–2427.
  • Kidd, K., K. Cusi, R. Mueller, et al. 2005. Detection and identification of significant ANAs in previously determined ANA negative samples. Clin. Lab. 51: 517–521.
  • Bossuyt, X., J. Frans, A. Hendrickx, et al. 2004. Detection of anti-SSA antibodies by indirect immunofluorescence. Clin. Chem. 50: 2361–2369.
  • Op De Beeck, K., P. Vermeersch, P. Verschueren, et al. 2011. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun. Rev. 10: 801–808.
  • Cabiedes, J., and C. A. Nunez-Alvarez. 2010. Antinuclear antibodies. Reumatol. Clin. 6: 224–230.
  • Tonuttia, E., D. Bassetti, A. Piazza, et al. 2004. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmnunity. 37: 171–176.
  • Meroni, P. L., and P. H. Schur. 2010. ANA screening: an old test with new recommendations. Ann. Rheum. Dis. 69: 1420–1422.
  • Bizzaro, N., and A. Wiik. 2004. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin. Exp. Rheumatol. 22: 349–355.
  • Burnham, T. K. 1972. Antinuclear antibodies in patients with malignancies. Lancet. 2: 436.
  • Abu-Shakra, M., D. Buskila, M. Ehrenfeld, et al. 2001. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann. Rheum. Dis. 60: 433–441.
  • Bei, R., L. Masuelli, C. Palumbo, et al. 2009. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: inflammation in their induction and impact on tumor growth. Cancer. Lett. 281: 8–23.
  • Ferlay, J., I. Soerjomataram, M. Ervik, et al. 2012. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr [last accessed date 30 September 2015]
  • Saif, M. W., A. Zalonis, and K. Syrigos. 2007. The clinical significance of autoantibodies in gastrointestinal malignancies: an overview. Expert. Opin. Biol. Ther. 7: 493–507.
  • Imai, H., R. L. Ochs, K. Kiyosawa, et al. 1992. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am. J. Pathol. 140: 859–870.
  • Al-Shukaili, A., A. A. Al-Jabri, and M. S. Al-Moundhri. 2006. Prognostic value of auto-antibodies in the serum of Omani patients with gastric cancer. Saudi. Med. J. 27: 1873–1877.
  • Syrigos, K. N., A. Charalambopoulos, K. Pliarchopoulou, et al. 2000. The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma. Anticancer. Res. 20: 4351–4353.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.